chr15-48752341-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001194998.2(CEP152):​c.3466+8G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.157 in 1,613,764 control chromosomes in the GnomAD database, including 28,309 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 7186 hom., cov: 32)
Exomes 𝑓: 0.15 ( 21123 hom. )

Consequence

CEP152
NM_001194998.2 splice_region, intron

Scores

2
Splicing: ADA: 0.000004609
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.533

Publications

13 publications found
Variant links:
Genes affected
CEP152 (HGNC:29298): (centrosomal protein 152) This gene encodes a protein that is thought to be involved with centrosome function. Mutations in this gene have been associated with primary microcephaly (MCPH4). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
CEP152 Gene-Disease associations (from GenCC):
  • microcephaly with or without short stature
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Seckel syndrome 5
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • microcephaly 9, primary, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 15-48752341-C-G is Benign according to our data. Variant chr15-48752341-C-G is described in ClinVar as Benign. ClinVar VariationId is 95653.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.508 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP152NM_001194998.2 linkc.3466+8G>C splice_region_variant, intron_variant Intron 21 of 26 ENST00000380950.7 NP_001181927.1 O94986-4Q3B7A2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP152ENST00000380950.7 linkc.3466+8G>C splice_region_variant, intron_variant Intron 21 of 26 1 NM_001194998.2 ENSP00000370337.2 O94986-4
CEP152ENST00000399334.7 linkc.3466+8G>C splice_region_variant, intron_variant Intron 21 of 25 1 ENSP00000382271.3 O94986-3
CEP152ENST00000325747.9 linkc.3187+8G>C splice_region_variant, intron_variant Intron 20 of 24 1 ENSP00000321000.5 O94986-1

Frequencies

GnomAD3 genomes
AF:
0.252
AC:
38280
AN:
151916
Hom.:
7161
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.514
Gnomad AMI
AF:
0.197
Gnomad AMR
AF:
0.189
Gnomad ASJ
AF:
0.0819
Gnomad EAS
AF:
0.471
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.142
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.126
Gnomad OTH
AF:
0.207
GnomAD2 exomes
AF:
0.194
AC:
48442
AN:
249462
AF XY:
0.182
show subpopulations
Gnomad AFR exome
AF:
0.527
Gnomad AMR exome
AF:
0.236
Gnomad ASJ exome
AF:
0.0827
Gnomad EAS exome
AF:
0.491
Gnomad FIN exome
AF:
0.140
Gnomad NFE exome
AF:
0.128
Gnomad OTH exome
AF:
0.142
GnomAD4 exome
AF:
0.147
AC:
214448
AN:
1461728
Hom.:
21123
Cov.:
32
AF XY:
0.144
AC XY:
104944
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.530
AC:
17745
AN:
33472
American (AMR)
AF:
0.234
AC:
10470
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0797
AC:
2082
AN:
26136
East Asian (EAS)
AF:
0.446
AC:
17715
AN:
39692
South Asian (SAS)
AF:
0.135
AC:
11609
AN:
86252
European-Finnish (FIN)
AF:
0.138
AC:
7361
AN:
53402
Middle Eastern (MID)
AF:
0.127
AC:
720
AN:
5688
European-Non Finnish (NFE)
AF:
0.123
AC:
136830
AN:
1111986
Other (OTH)
AF:
0.164
AC:
9916
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
10733
21466
32198
42931
53664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5318
10636
15954
21272
26590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.252
AC:
38338
AN:
152036
Hom.:
7186
Cov.:
32
AF XY:
0.251
AC XY:
18665
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.514
AC:
21307
AN:
41458
American (AMR)
AF:
0.189
AC:
2892
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0819
AC:
284
AN:
3466
East Asian (EAS)
AF:
0.472
AC:
2433
AN:
5160
South Asian (SAS)
AF:
0.154
AC:
740
AN:
4818
European-Finnish (FIN)
AF:
0.142
AC:
1503
AN:
10558
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.126
AC:
8541
AN:
67964
Other (OTH)
AF:
0.205
AC:
432
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1247
2494
3740
4987
6234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.113
Hom.:
434
Bravo
AF:
0.274
Asia WGS
AF:
0.296
AC:
1028
AN:
3478
EpiCase
AF:
0.125
EpiControl
AF:
0.123

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Dec 18, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jul 03, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Microcephaly 9, primary, autosomal recessive Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Seckel syndrome 5 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
3.7
DANN
Benign
0.42
PhyloP100
0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000046
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2306187; hg19: chr15-49044538; COSMIC: COSV57857859; API